Lamotrigine

Lamotrigine (brand name Lamictal) is an anticonvulsant that has quietly become one of the most useful mood stabilisers in psychiatry. Its main job for most people who take it is preventing the depressive episodes of bipolar disorder, especially bipolar II, where depression is the dominant and most disabling phase. It's the only mood stabiliser that's clearly better at preventing depression than mania, which is the opposite pattern to lithium.

It doesn't sedate you, it doesn't blunt you, it doesn't cause weight gain, and at therapeutic doses most people barely feel they're on it. That's the appeal. The catch is the titration schedule, you have to go up slowly over 5-6 weeks to avoid a rare but serious skin reaction (Stevens-Johnson syndrome), and you can't skip doses without restarting. If you're looking at it for bipolar II, recurrent unipolar depression, or as an add-on when an SSRI alone isn't holding, this is the page.

Deep-dive

Lamotrigine is a phenyltriazine, structurally distinct from any other mood stabiliser. Its primary action is voltage-dependent blockade of sodium channels, specifically the slow inactivation state that occurs when neurons are firing rapidly. It also blocks N- and P-type calcium channels in focal brain regions. The downstream effect is reduced release of glutamate and aspartate, the brain's two main excitatory neurotransmitters. Crucially, it only damps down hyperactive firing, it doesn't suppress normal baseline activity, which is why it's not sedating the way benzodiazepines or other anticonvulsants are.

This explanation is incomplete though. Other anticonvulsants like phenytoin, oxcarbazepine, and topiramate also block sodium channels but don't act as mood stabilisers. Something else is going on. Candidate mechanisms include modulation of 5-HT1A receptor signalling, mild GABA enhancement, effects on BDNF and neuroplasticity, and possibly sigma-1 receptor activity. One imaging trial in healthy volunteers found a single dose shifted emotional processing toward positive bias in the amygdala and prefrontal cortex, a pattern that overlaps with how SSRIs change brain function, which may explain why it works in depression without acting like a classical antidepressant.

Bipolar maintenance. The strongest evidence is here. Two 18-month placebo-controlled trials (Calabrese 2003 and Bowden 2003) compared lamotrigine, lithium, and placebo in bipolar I patients stabilised after a depressive or manic episode. Both drugs beat placebo for preventing any mood episode. The split was clean: lamotrigine was better at preventing depression, lithium was better at preventing mania. This is the basis of the FDA approval and the reason psychiatrists reach for lamotrigine when the depressive pole is the main problem, which it usually is in bipolar II.

Acute bipolar depression. Weaker. The pooled analysis of five GSK trials of lamotrigine as acute monotherapy for bipolar depression found a modest effect overall, statistically significant only in the more severely depressed subgroup. As an add-on to lithium or an antidepressant, it tends to perform better than as monotherapy. The honest takeaway is that lamotrigine is a prevention drug more than an acute rescue drug, you take it to stop the next episode, not to lift you out of this one.

Unipolar depression. Used off-label as an augmentation strategy when an SSRI or SNRI isn't fully working, especially in patients whose depression has a recurrent, episodic, or mood-lability pattern that resembles bipolar without meeting full criteria. The evidence is weaker than for bipolar but the clinical practice is widespread.

Borderline personality disorder. Frequently prescribed off-label for the affective instability and impulsivity of BPD, but the evidence didn't hold up under scrutiny. The LABILE trial, a large NIHR-funded RCT with 12-month follow-up, found no benefit over placebo on BPD symptoms, mood, social functioning, or self-harm. A 2020 meta-analysis of all available RCTs reached the same conclusion. Patient-reported experience on forums is more positive than the trial data, Drugs.com reviews for off-label BPD use sit around 8/10, which is a real signal but doesn't survive rigorous controlled comparison. If you have BPD and lamotrigine is working for you, that's fine, but the controlled evidence says don't expect much from a fresh start.

Epilepsy. This is the original indication. Broad-spectrum efficacy for partial seizures, primary generalised tonic-clonic, and Lennox-Gastaut. Outside the scope of why most people end up on this page, but worth knowing because the long epilepsy safety record (decades, large populations) is the main reason we have confidence in lamotrigine's long-term tolerability.

Cognition. One of lamotrigine's quiet wins. Head-to-head trials against carbamazepine showed significantly better performance on cognitive and behavioural measures, and against topiramate it preserved cognitive function much better. Most people on therapeutic doses report no cognitive impact at all, which is unusual in this drug class.

Weight. Neutral. Across bipolar trials, lamotrigine didn't cause meaningful weight change in either direction, including when combined with other psychotropics. This matters because valproate, olanzapine, and quetiapine, the main alternatives, are all associated with significant weight gain.

Women. This is where lamotrigine gets genuinely interesting and where most prescribing goes wrong. Oestrogen powerfully induces UGT1A4, the liver enzyme that metabolises lamotrigine. The clinical consequence is that combined oral contraceptives (anything with ethinyl estradiol) drop lamotrigine plasma levels by roughly 50%, with a range of 41-64%. Starting the pill on a stable lamotrigine dose can cause breakthrough depression or seizures. Stopping the pill on the same lamotrigine dose can cause toxicity. During the hormone-free week of cyclical pills, lamotrigine levels can nearly double, causing dizziness, nausea, and ataxia for a week each month. This is fixable, you adjust the lamotrigine dose to match the contraceptive regimen, use continuous-dosing pills with no hormone-free interval, or switch to a non-hormonal IUD or progestin-only method, which don't appear to interact. But if no one explains the interaction, women cycle through what looks like treatment failure when it's actually a pharmacokinetic problem.

Pregnancy multiplies this effect. Oestrogen rises continuously through gestation and lamotrigine clearance can more than double by the third trimester, requiring substantial dose increases to maintain effect, followed by rapid downward adjustment postpartum to avoid toxicity. Lamotrigine has the cleanest pregnancy safety profile of any mood stabiliser (valproate is teratogenic, lithium has cardiac risk, carbamazepine has neural tube risk), so it's often the first choice for women planning pregnancy, but the dosing has to be actively managed.

There's also a small literature on premenstrual dysphoric disorder. Case reports describe lamotrigine augmentation working in SSRI-resistant PMDD, and a GSK-sponsored observational study in women with epilepsy found higher lamotrigine serum levels correlated with milder PMDD symptoms. It's not first-line for PMDD (SSRIs and the contraceptive Yaz are), but for women whose mood lability has a strong cyclical component layered on a depressive baseline, lamotrigine is worth a discussion with a prescriber.

Onset. Slow. By the time you finish the 5-6 week titration you're just reaching therapeutic dose. Full mood-stabilising effect typically lands at 2-3 months, sometimes longer. Don't judge it before week 8 at therapeutic dose.

Dosage:

Titration is non-negotiable. Standard schedule is 25 mg/day for weeks 1-2, 50 mg/day for weeks 3-4, 100 mg/day for week 5, 200 mg/day from week 6. Going faster than this is the main driver of serious rash. Going slower is fine and often preferred for cautious prescribers

Target maintenance dose for bipolar: 200 mg/day, usually as a single daily dose or split into 100 mg twice daily. Some patients respond at 100 mg, others need 300-400 mg. The 50/200/400 mg arms in the Calabrese 2003 trial all worked, with the larger doses showing slightly better depression prevention

Target for epilepsy: typically 200-400 mg/day, sometimes higher

If you miss 3+ consecutive days, restart from week 1. Tolerance to the rash risk is lost. This is a real constraint, the pill is a daily commitment

Valproate combination: valproate doubles lamotrigine levels by inhibiting glucuronidation. If you're on valproate, the titration starts at 25 mg every other day and the target dose halves. Most serious rashes in the older literature came from prescribers ignoring this

Hormonal contraceptives (combined pills, patch, ring): lamotrigine dose typically needs to be 1.5-2x higher than without contraception. Starting or stopping the pill is a dose-adjustment event. Progestin-only and copper IUD don't require adjustment

Pregnancy: dose typically needs to rise through gestation, sometimes 2-3x baseline, then taper back rapidly postpartum. Levels and clinical state should be checked each trimester. Don't manage this without a prescriber experienced with antiepileptics in pregnancy

Timing: once-daily dosing is fine for most people. Some prefer evening to minimise daytime drowsiness during titration, others prefer morning if it disrupts sleep

Stacks: safe with most antidepressants. Common combinations are lamotrigine with an SSRI (
Escitalopram (Lexapro),
Zoloft (Sertraline)) for bipolar depression, lamotrigine with
Bupropion (Wellbutrin) for activation, lamotrigine with lithium for full-spectrum bipolar coverage. Avoid stacking with carbamazepine without dose adjustment (carbamazepine halves lamotrigine levels)

Here's what you can expect:

For the first 4-6 weeks during titration, most people feel nothing. You're below therapeutic dose. Don't expect mood effects yet. What you're looking for in this window is a rash, anywhere on the body, especially with fever, mouth sores, eye irritation, or feeling generally unwell. If that happens, stop and call your prescriber immediately. If you sail through titration without skin issues, you're almost certainly clear.

From week 6-8 onward at 200 mg, the effect tends to be subtle. Most people describe it as a flattening of the depressive troughs rather than a lift in mood. Bad days are less bad. The slide into a depressive episode that you'd normally feel coming a few weeks out either doesn't happen or stops earlier. The texture of daily life feels steadier. It's not a stimulant or an antidepressant, you don't feel "on" anything.

Full stabilisation typically takes 2-3 months at therapeutic dose. The clinical benefit shows up over months and years, in the form of fewer and shorter depressive episodes, not days. Most people who do well on lamotrigine stay on it for years.

Side effects & risks:

Serious rash (Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS). This is the FDA black-box warning and the main reason for slow titration. Baseline risk is roughly 1 in 1000 for adults, 1 in 100 for kids, dropping to roughly 1 in 10,000 with proper slow titration. Almost all serious rashes occur in the first 2-8 weeks. The first sign is usually a maculopapular rash, often with fever, mouth or eye involvement, or feeling flu-like. Any rash in the first 2 months means stop the drug and contact your prescriber the same day. Benign rashes also occur (around 8-10% of people get some skin reaction during titration), which is why proper dermatology assessment matters before assuming the worst

HLA-B*15:02 allele, found in roughly 10-15% of Han Chinese, Thai, Malay, and other Southeast Asian populations, is associated with elevated SJS/TEN risk. HLA testing before starting is standard practice in some Asian countries and worth requesting if you have relevant ancestry

Headache, dizziness, nausea, blurred or double vision are common in the first weeks, usually dose-dependent and resolve as your system adjusts or with slower titration

Insomnia or vivid dreams in some people, especially at higher doses. Moving the dose to morning sometimes helps

Tremor in a minority of users, usually dose-dependent

Mood activation or rare manic switch. Less common than with classical antidepressants, but possible. Worth tracking if you're on it for bipolar

Suicidality warning. The FDA class label for antiepileptics includes a small increased risk of suicidal thoughts. The signal is weak and not specific to lamotrigine, but worth knowing

Drug interactions to know: combined oral contraceptives (drop levels by ~50%), valproate (doubles levels, halve the lamotrigine dose), carbamazepine/phenytoin/rifampin (drop levels), pregnancy (levels fall through gestation). Most other psychotropics, including SSRIs, are compatible without dose adjustment

Withdrawal. No physical dependence or addiction potential, but abrupt discontinuation of an effective mood stabiliser can trigger relapse of the underlying disorder. Taper over weeks if stopping

🩸

Blood markers

CBC (complete blood count) and liver function (ALT, AST, alkaline phosphatase), baseline before starting and at any sign of systemic illness during titration. DRESS, the multi-organ hypersensitivity reaction, shows up as eosinophilia and elevated liver enzymes alongside the rash. Routine periodic monitoring isn't required for stable patients but a baseline gives you the comparison point you'd want if something appears.

Lamotrigine serum level, optional but useful in specific situations: when starting or stopping a combined oral contraceptive, during pregnancy (each trimester), when adding or removing an interacting drug (valproate, carbamazepine), or when symptoms re-emerge on a previously stable dose. The therapeutic range is loosely 3-15 µg/mL but clinical response matters more than the number.

Pregnancy planning labs and HLA-B*15:02 if you have East or Southeast Asian ancestry, before starting. These two checks prevent the avoidable bad outcomes.

For typical bipolar maintenance on a stable dose without other medications changing, no routine bloodwork is required after the baseline. This is one of the simpler psychiatric drugs to manage on labs, unlike lithium which needs regular level checks and renal monitoring (no dedicated page yet, worth adding).

Lamotrigine is a prescription-only medication and should be initiated and titrated under medical supervision.